BHC — Bausch Health Companies Share News
0.000.00%
Last trade - 00:00- $1.89bn
- $22.37bn
- $10.27bn
Canada's Bausch Health Q1 revenue rises
Canada's Bausch Health beats Q1 adjusted EPS estimates
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case
Canada Stocks: TSX subdued as healthcare, financials drag; energy gains
Canada's Bausch Health Q4 revenue rises 9%, reports net loss
Bausch Health falls after brain dysfunction treatment fails late-stage trials
Bausch Health's brain dysfunction treatment fails late-stage trials (updated)
Bausch Health's brain dysfunction treatment fails late-stage trial
Brief: Bausch Health Provides Update On RED-C Phase 3 Clinical Trials
Brief: Bausch Health Announces Launch Of Offers To Exchange Certain Existing Senior Secured Notes
Media: Bausch seeks to push out 2028 debts in $3.4 billion bond exchange - Bloomberg News
Canada Stocks: TSX set for weekly decline as investors assess key jobs data
Bausch, Teva accused of delaying generic version of diarrhea drug Xifaxan
Brief: Bausch Health Completes Acquisition Of Durect Corporation, Expanding Late-Stage Liver Disease Portfolio
Bausch + Lomb board members resign after Icahn agreement ends (updated)
Canada Stocks: Toronto stocks subdued on Friday, closes green for the week
Bausch Health Companies Inc reports results for the quarter ended June 30 - Earnings Summary
Bausch Health Companies Inc expected to post earnings of 97 cents a share - Earnings Preview
Brief: Bausch Health Companies Inc - Enters Agreements With Icahn, Paulson, Kavanagh Groups - SEC Filing